2026年8月4日 21:06 ET 发布 · 更新于 3 个月前 · 1 个来源
Goldman-Backed Biotech Attovia Raises $289 Million in US IPO
bloomberg
·
原始报道
Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.
原文